UBS Group AG - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 79 filers reported holding HUMACYTE INC in Q2 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$97,909
+3.8%
33,416
+1.3%
0.00%
Q2 2023$94,331
+48.3%
32,983
+60.2%
0.00%
Q1 2023$63,605
+868.0%
20,584
+561.0%
0.00%
Q4 2022$6,571
-79.5%
3,114
-68.3%
0.00%
Q3 2022$32,000
+100.0%
9,827
+92.0%
0.00%
Q2 2022$16,000
-99.1%
5,117
-97.9%
0.00%
-100.0%
Q4 2021$1,750,000
+19344.4%
241,374
+30924.9%
0.00%
Q3 2021$9,0007780.00%
Other shareholders
HUMACYTE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders